| 1 |
27564113 | Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo. | 2017 Jan 24 |
1 |
| 2 |
24408322 | Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations. | 2014 Mar 6 |
2 |
| 3 |
24596204 | Ponatinib circumvents FGF2-driven resistance to imatinib in CML. | 2014 Mar |
1 |
| 4 |
24771645 | FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies. | 2014 Jun 15 |
1 |
| 5 |
24966347 | Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma. | 2014 Oct |
1 |